MHRA approves new diagnostic agent for adult patients showing signs of cognitive impairment for Alzheimer’s disease

Twitter

Linkedin

Facebook

email

The Medicines and Healthcare products Regulatory Agency has approved the medicine flortaucipir (Tauvid), given to adults with memory problems so that doctors can perform a type of brain scan called a PET.

Follow this news feed: